To Avoid Pharma Tariffs, U.K. Agrees to Trump’s Demand to Pay More for Drugsnews2025-12-01T19:42:09+00:00December 1st, 2025|The New York Times|
U.S. Announces Negotiated Prices for 15 Drugs Under Medicarenews2025-11-26T03:09:55+00:00November 26th, 2025|The New York Times|
Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Valuenews2025-11-21T21:25:40+00:00November 21st, 2025|The New York Times|
RFK Jr. Walks a Tightrope on Trump Deal for Obesity Drugsnews2025-11-14T10:02:07+00:00November 14th, 2025|The New York Times|
What Trump’s New Drug Pricing Deal Means for People With Obesitynews2025-11-06T21:53:59+00:00November 6th, 2025|The New York Times|
Why Medicare Recipients Should Check Their 2026 Drug Plans Nownews2025-11-01T09:00:46+00:00November 1st, 2025|The New York Times|
F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugsnews2025-10-29T20:07:07+00:00October 29th, 2025|The New York Times|
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Pricesnews2025-10-23T09:00:45+00:00October 23rd, 2025|The New York Times|
Trump Announces Proposals to Make I.V.F. More Affordablenews2025-10-17T00:17:15+00:00October 17th, 2025|The New York Times|
Trump Cuts a Deal With AstraZeneca to Lower Drug Pricesnews2025-10-11T00:24:13+00:00October 11th, 2025|The New York Times|
